Skip to content

Insider · CIK 0001895944

John M Wesolowski

officer

Files at INTS (INTENSITY THERAPEUTICS, INC.). First filing -, latest -.

In brief

John M Wesolowski files SEC Form 4 as officer at INTS (INTENSITY THERAPEUTICS, INC.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.

A track record needs three past buys with six months of prices behind them; John M Wesolowski has 0, so none is measured yet.

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold

Signals

This insider’s open-market buys and sells, scored.

No scored open-market trades yet.

Transactions

Every row this insider has filed, 7 in all, newest first.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
Jul 16, 2026INTS
INTENSITY THERAPEUTICS, INC.
AGrant or award
Stock Option (right to buy Common Stock)derivative
+11,000$0.00$011,000Jul 20, 2026
Jun 30, 2026INTS
INTENSITY THERAPEUTICS, INC.
AGrant or award
Common Stock, $0.0001 Par Value
+3,688$3.49$13k7,102Jul 1, 2026
Dec 31, 2025INTS
INTENSITY THERAPEUTICS, INC.
AGrant or award
Common Stock, $0.0001 Par Value
+8,918$0.26$2,33785,354Jan 5, 2026
Jun 30, 2025INTS
INTENSITY THERAPEUTICS, INC.
AGrant or award
Common Stock, $0.0001 Par Value
+69,745$0.26$18k76,436Jul 2, 2025
May 2, 2025INTS
INTENSITY THERAPEUTICS, INC.
AGrant or award
Stock Option (right to buy Common Stock)derivative
+100,000$0.00$0100,000May 6, 2025
May 2, 2025INTS
INTENSITY THERAPEUTICS, INC.
AGrant or award
Stock Option (right to buy Common Stock)derivative
+100,000$0.00$0100,000May 6, 2025
Oct 21, 2024INTS
INTENSITY THERAPEUTICS, INC.
AGrant or award
Stock Option (right to buy Common Stock)derivative
+70,028$0.00$070,028Oct 23, 2024

Questions about John M Wesolowski

Answered from the filings on this page, as of the latest one.

Is John M Wesolowski buying or selling?

John M Wesolowski has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.

How did John M Wesolowski's past buys perform?

Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and John M Wesolowski has 0.

Where does John M Wesolowski file Form 4?

John M Wesolowski has filed Form 4 at INTS (INTENSITY THERAPEUTICS, INC.) as Principal Accounting Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

John M Wesolowski: insider trades and track record | InsiderTell